| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ICHOR HOLDINGS, LTD. | Director | Ordinary Shares, par value $0.0001 | 28.3K | $1.24M | $43.83 | May 15, 2024 | Direct |
| Protagonist Therapeutics, Inc | Director | Stock Option (right to buy) | 25.7K | Jan 2, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ICHR | ICHOR HOLDINGS, LTD. | May 15, 2024 | 1 | $0 | 4 | May 17, 2024 | Director |
| PTGX | Protagonist Therapeutics, Inc | Jan 2, 2024 | 1 | $0 | 4 | Jan 4, 2024 | Director |
| ICHR | ICHOR HOLDINGS, LTD. | May 18, 2023 | 1 | $0 | 4 | May 22, 2023 | Director |
| PTGX | Protagonist Therapeutics, Inc | Jan 16, 2023 | 1 | $0 | 4 | Jan 18, 2023 | Director |
| PTGX | Protagonist Therapeutics, Inc | May 26, 2022 | 1 | $0 | 4 | May 27, 2022 | Director |
| ICHR | ICHOR HOLDINGS, LTD. | May 24, 2022 | 1 | $0 | 4 | May 26, 2022 | Director |
| PTGX | Protagonist Therapeutics, Inc | May 27, 2021 | 1 | $0 | 4 | May 28, 2021 | Director |
| ICHR | ICHOR HOLDINGS, LTD. | May 11, 2021 | 1 | $0 | 4 | May 14, 2021 | Director |